Table 3 Hematological and blood biochemical measurements of the 71 age-matched pediatric IA and COVID-19 patient pairs: abnormally high or lowa
| Â | IyesCyes | IyesCno | InoCyes | InoCno | P | OR (95% CI) |
|---|---|---|---|---|---|---|
Blood routine (n = 59) | ||||||
 Lymphocytes | ||||||
  Count abnormally low | 5 (8.5) | 22 (37.3) | 4 (6.8) | 28 (47.5) | < 0.01 | 5.50 (1.90–16.0) |
  Percentage abnormally low | 3 (5.1) | 19 (32.2) | 2 (3.4) | 35 (59.3) | < 0.01 | 9.50 (2.21–40.8) |
Neutrophils | ||||||
  Count abnormally low | 4 (6.8) | 2 (3.4) | 19 (32.2) | 34 (57.6) | < 0.01 | 0.11 (0.02–0.45) |
  Percentage abnormally low | 0 (0) | 0 (0) | 6 (10.2) | 53 (89.8) | 0.03 | 0.00 (0.00–0.85) |
 Hemoglobin | ||||||
  Abnormally low | 4 (6.8) | 13 (22.0) | 2 (3.4) | 40 (67.8) | < 0.01 | 6.50 (1.47–28.8) |
Coagulation function (n = 51) | ||||||
 APPT (s) †| ||||||
  Abnormally high | 2 (3.9) | 18 (35.3) | 0 (0) | 31 (60.8) | < 0.01 | – |
 PT (s) †| ||||||
  Abnormally high | 0 (0) | 13 (25.5) | 0 (0) | 38 (74.5) | < 0.01 | – |
Blood biochemistry | ||||||
 C-reactive protein (n = 61) | ||||||
  Abnormally high | 5 (8.2) | 24 (39.3) | 7 (11.5) | 25 (41.0) | < 0.01 | 3.43 (1.48–7.96) |
 Procalcitonin (n = 44) | ||||||
  Abnormally high | 10 (22.7) | 28 (63.6) | 3 (6.8) | 3 (6.8) | < 0.01 | 9.33 (2.84–30.7) |